AI Article Synopsis

  • Non-steroidal anti-inflammatory drugs, while effective for inflammation, carry risks of negative side effects, leading to interest in compounds that blend anti-inflammatory and antioxidant properties.
  • The study utilized deep learning, specifically a one-dimensional convolutional neural network, to classify and predict the efficacy of compounds that inhibit inflammatory enzymes and scavenge free radicals.
  • The results showed high accuracy in identifying dual active compounds and in predicting the effectiveness of newly synthesized anti-inflammatory agents, aiding in future therapeutic applications.

Article Abstract

Even though non-steroidal anti-inflammatory drugs are the most effective treatment for inflammatory conditions, they have been linked to negative side effects. A promising approach to mitigating potential risks, is the development of new compounds able to combine anti-inflammatory with antioxidant activity to enhance activity and reduce toxicity. The implication of reactive oxygen species in inflammatory conditions has been extensively studied, based on the pro-inflammatory properties of generated free radicals. Drugs with dual activity (i.e., inhibiting inflammation related enzymes, e.g., LOX-3 and scavenging free radicals, e.g., DPPH) could find various therapeutic applications, such as in cardiovascular or neurodegenerating disorders. The challenge we embarked on using deep learning was the creation of appropriate classification and regression models to discriminate pharmacological activity and selectivity as well as to discover future compounds with dual activity prior to synthesis. An accurate filter algorithm was established, based on knowledge from compounds already evaluated in vitro, that can separate compounds with low, moderate or high activity. In this study, we constructed a customized highly effective one dimensional convolutional neural network (CONV1D), with accuracy scores up to 95.2%, that was able to identify dual active compounds, being LOX-3 inhibitors and DPPH scavengers, as an indication of simultaneous anti-inflammatory and antioxidant activity. Additionally, we created a highly accurate regression model that predicted the exact value of effectiveness of a set of recently synthesized compounds with anti-inflammatory activity, scoring a root mean square error value of 0.8. Eventually, we succeeded in observing the manner in which those newly synthesized compounds differentiate from each other, regarding a specific pharmacological target, using deep learning algorithms.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9774961PMC
http://dx.doi.org/10.3390/bioengineering9120800DOI Listing

Publication Analysis

Top Keywords

deep learning
12
synthesized compounds
12
compounds
8
inflammatory conditions
8
anti-inflammatory antioxidant
8
activity
8
antioxidant activity
8
free radicals
8
dual activity
8
contribution deep
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!